Federal Nursing Home Staffing Rule Is Gone, Now It’s Up to the States

In announcing the move, health agency officials stated that the rule would have imposed too high a burden on nursing homes, particularly in rural areas, where they noted that nursing staff are in ...

Nonprofit Born From Ashes of 23andMe Hires Former Pfizer Heavyweight as GC

The 23andMe Research Institute bought the company's assets for $305 million, scotching a proposed sale to Regeneron ...
Westchester Magazine

A Look at Regeneron’s Plans Following Its 23andMe Bid

When the mail-in ancestry company 23andMe filed for bankruptcy, Regeneron Pharmaceuticals stepped in to snap it up. Though in the end the Tarrytown-based company was outbid, the scenario raised a ...
BioSpace

Regeneron Showcases Advances Across Oncology Portfolio and Pipeline at ESMO, Highlighting Novel and Patient-Focused Approach for Difficult-to-Treat Cancers

New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell carcinoma ...
Standard-Examiner

Utah AG issues consumer advisory for 23andMe customers

Following the sale of the direct-to-consumer genetic testing company 23andMe, the Utah Attorney General’s Office is issuing a consumer advisory reminding former customers of ways to protect their ...
Insider Monkey

Regeneron Pharmaceuticals, Inc. (REGN) Acquires 23andMe Assets in $256M Deal

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Regeneron Pharmaceuticals, Inc. tops our list for being one of the most undervalued healthcare stocks ...
news.bloomberglaw

23andMe Ombudsman Beats DOJ Pushback in Bid to Hire WilmerHale

23andMe’s privacy ombudsman secured court approval to retain WilmerHale in the DNA testing company’s Chapter 11 case despite an objection from the Justice Department’s bankruptcy watchdog over ...
Insider Monkey

10 Most Undervalued Healthcare Stocks to Buy According to Analysts

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the most undervalued stocks. It is a leading American biotech company specializing in treatments for serious diseases across ophthalmology, ...
EurekAlert!

Genetic test predicts obesity in childhood

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global population to develop overweight or obesity by 2035. However, treatment ...
Yahoo

23andMe has officially been sold: What will happen to customers’ data?

The sale of 23andMe was finalized this week, following the company filing for bankruptcy in March. The sale was previously approved by a judge. The company was purchased by the nonprofit TTAM Research ...
NBC New York

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly's Zepbound

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Another ...